Technology

UiPath Stock Edges Up but Lags Tech Rally as Buyback Hopes Face ARR Slowdown

UiPath shares edged up 0.5% but underperformed the broader tech rally. UBS cut its target to $12, and Q2 ARR guidance points to slower growth, keeping pressure on the stock.

Sarah Chen · · · 3 min read · 6 views
UiPath Stock Edges Up but Lags Tech Rally as Buyback Hopes Face ARR Slowdown
Mentioned in this article
PATH $10.81 +1.22% QQQ $736.24 +1.68% UBS $49.48 -0.02%

UiPath (NYSE:PATH) shares managed a modest gain in Tuesday's trading session, rising approximately 0.5% to $10.735, but the move fell well short of the broader technology rally. The Invesco QQQ Trust (NASDAQ:QQQ), which tracks the Nasdaq-100, surged 1.6% on the same day, highlighting the relative underperformance of the automation software company. Trading volume exceeded 35 million shares, and the company's market capitalization stood at roughly $5.67 billion.

Analyst Downgrade Adds Pressure

The stock's tepid performance comes on the heels of a price target cut by UBS. Analyst Radi Sultan lowered his target to $12 from $13 on June 29, maintaining a Neutral rating. The revision reflects ongoing concerns about the company's growth trajectory, particularly its annual recurring revenue (ARR) outlook. The stock now trades at a significant discount to its 52-week highs, with investors waiting for concrete signs of a growth inflection.

ARR Growth Deceleration in Focus

UiPath's financial filings reveal a critical challenge: the pace of net new ARR is expected to slow in the second quarter. The company added $49 million in net new ARR during the first quarter, but its Q2 guidance implies an addition of only $28 million to $33 million for the period from April 30 to July 31. This deceleration is a key reason the stock has not participated more fully in the AI-driven rally seen by many large-cap tech names. As of April 30, total ARR stood at $1.901 billion, and the company expects it to reach between $1.929 billion and $1.934 billion by July 31.

Buyback Capacity Provides a Floor

One of the few bright spots for shareholders is the company's substantial share repurchase authorization. According to UiPath's June 4 quarterly filing, the company had $436.9 million remaining in its buyback program as of April 30. Between May 1 and May 15, UiPath repurchased 2.4 million shares at an average price of $9.63, leaving approximately $414 million—or about 7.3% of the current market cap—available for further buybacks. This sizable authorization could help support the stock price, but it also raises questions about whether the company is prioritizing capital return over reinvestment in growth.

Strong Cash Position, but Capital Allocation Questions

UiPath's balance sheet remains robust. The company reported $1.416 billion in cash, cash equivalents, and marketable securities as of April 30, representing roughly 25% of its market cap. First-quarter revenue came in at $418.4 million, up 17% year-over-year, and operating cash flow was $131.9 million. However, the company has been using its cash for acquisitions and share repurchases, and future buybacks remain discretionary. The strong liquidity provides a cushion, but it also underscores the market's demand for faster ARR growth to justify the valuation.

Annual Meeting and Board Updates

UiPath held its annual meeting on June 25, and the subsequent 8-K filing on June 29 confirmed the re-election of all seven board members, approval of the say-on-pay proposal, and the ratification of KPMG as auditor for the fiscal year ending January 31, 2027. Shareholder participation was high, with 93.78% of voting power represented. Separately, Form 4 filings on June 29 showed standard equity awards to non-employee directors, including Philippe Botteri, Karenann Terrell, Daniel Springer, Michael Gordon, Richard P. Wong, and June Yang, each receiving 19,175 RSUs.

Outlook Hinges on Q2 ARR and Buyback Activity

With no major investor events on the calendar following the annual meeting, UiPath's near-term stock performance will likely be driven by two factors: whether the company delivers on its Q2 ARR guidance and the pace of its share repurchases. CEO Daniel Dines characterized the first quarter as a "strong start to the fiscal year" and noted that new agentic products are "moving from pilot to production." CFO and COO Ashim Gupta added that results were "exceeding our guidance" thanks to "continued operational discipline." Nonetheless, until the ARR growth trajectory shows a sustained improvement, UiPath may continue to lag its tech peers.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →